ABOUT ORIVISE
Diagnostics R&D judgement for assay problems and development decisions.
ORIVISE brings independent diagnostics R&D judgement to the decisions that shape diagnostic products, from early feasibility to transfer. It helps diagnostics teams resolve recurring assay problems, assess development readiness and lead defined R&D work, with a separate offer for innovation programmes.
Dr Pompi Hazarika
Experience across science, teams and development.
PhD, TU Dortmund, Germany · MSc, IIT Guwahati, India · Executive MBA Candidate, University of Birmingham, UK
I have more than 20 years of experience across scientific research and diagnostics R&D. I worked at The Binding Site from 2013 to 2025, including after it became part of Thermo Fisher Scientific in 2023. During that time, I led teams and worked across feasibility, troubleshooting and new product development for diagnostic projects and platforms.
I founded ORIVISE to bring that judgement to diagnostics teams and the organisations that fund and support them. I examine the evidence behind a result, ask what could fail as the technology develops and help teams prioritise what to prove, fix or decide next.
Having trained and worked across India, Germany and the UK, I'm used to working with international teams, partners and suppliers, where clear technical communication matters as much as the science.
SCIENTIFIC DEPTH
Chemistry, biochemistry and diagnostics expertise.
My expertise sits at the intersection of chemistry, biochemistry and diagnostics development. I combine experience in immunoassays, protein purification, bioconjugation and particle-based reagents with the ability to investigate how molecular interactions and reagent properties affect assay performance, stability and reproducibility.
Why ORIVISE exists
Good science still needs the right questions.
A promising diagnostic can stall because the evidence does not yet support its proposed use, an important development assumption remains untested, or the team has not spoken to the people who would use it. These questions are easier to address before a funding, transfer or implementation decision becomes difficult to reverse.
ORIVISE helps teams examine the technical case and decide what to test next. Clinical fit, workflow, economics and adoption matter too. I bring those questions into the discussion early and work alongside appropriate specialists when they require expertise beyond my own.
My approach
Independent
An outside view of the evidence and assumptions, with no prior development decision to defend.
Evidence led
Conclusions tied to the data available and the decision it is being asked to support.
Practical
Recommendations that tell a team what to investigate, change or decide next.
Supportive
Clear challenge that helps founders and scientists build their own judgement.
Discuss a project or decision.
Tell me what you are trying to establish and the decision you face.